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Gangliosides are widely expressed sialylated glycosphingolipids withmultifunctional properties in different cell types and organs. In the
nervous system, they are highly enriched in both glial and neuronal membranes. Mice lacking complex gangliosides attributable to
targeted ablation of the B4galnt1 gene that encodes -1,4-N-acetylegalactosaminyltransferase 1 (GalNAc–transferase; GalNAcT/)
develop normally before exhibiting an age-dependent neurodegenerative phenotype characterized bymarked behavioral abnormalities,
central andperipheral axonal degeneration, reducedmyelin volume, and loss of axo-glial junction integrity. The cell biological substrates
underlying this neurodegeneration and the relative contribution of either glial or neuronal gangliosides to the process are unknown. To
address this, we generated neuron-specific and glial-specific GalNAcT rescue mice crossed on the global GalNAcT/ background
[GalNAcT/-Tg(neuronal) andGalNAcT/-Tg(glial)] and analyzed their behavioral,morphological, and electrophysiological phenotype.
Complex gangliosides, as assessedby thin-layer chromatography,mass spectrometry,GalNAcTenzymeactivity, andanti-ganglioside antibody
(AgAb) immunohistology, were restored in both neuronal and glial GalNAcT rescuemice. Behaviorally,GalNAcT/-Tg(neuronal) retained a
normal “wild-type” (WT) phenotype throughout life, whereas GalNAcT/-Tg(glial) resembled GalNAcT/ mice, exhibiting progressive
tremor, weakness, and ataxia with aging. Quantitative electronmicroscopy demonstrated thatGalNAcT/ andGalNAcT/-Tg(glial) nerves
had significantly increased rates of axon degeneration and reduced myelin volume, whereas GalNAcT/-Tg(neuronal) and WT appeared
normal. The increased invasion of the paranode with juxtaparanodal Kv1.1, characteristically seen in GalNAcT/ and attributed to a break-
downoftheaxo-glial junction,wasnormalizedinGalNAcT/-Tg(neuronal)butremainedpresent inGalNAcT/-Tg(glial)mice.Theseresults
indicate that neuronal rather than glial gangliosides are critical to the age-relatedmaintenance of nervous system integrity.
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Introduction
Gangliosides are sialylated glycosphingolipids widely expressed
in vertebrate plasmamembranes and intracellular compartments
(Ledeen and Wu, 2011; Yu et al., 2011; Sandhoff and Harzer,
2013). They are particularly enriched in nervous system gray and
whitematter, in which they have roles in development andmain-
tenance, cell–cell recognition, signal transduction, growth, and
motility. They are key components of lipid raft membrane do-
mains (Sonnino et al., 2007; Ohmi et al., 2012) and function as
receptors for microbial pathogens and toxins (Fewou et al., 2013;
Ravindran et al., 2013) and neuropathy-associated auto-anti-
bodies (Willison and Yuki, 2002; Kusunoki et al., 2008).
Gangliosides are synthesized by stepwise addition of mono-
saccharides to ceramide by glycosyltransferases (Hakomori,
1981; Yu et al., 2004; Fig. 1B). The predominant gangliosides
found in neural tissue are the complex gangliosides GM1, GD1a,
GD1b, and GT1b, likely because of high activity of their syn-
thesizing enzyme, -1,4-N-acetylegalactosaminyltransferase
1 (GalNAc–transferase; GalNAcT, encoded by the B4galnt1
gene) in the nervous system (Dicesare and Dain, 1971). Trans-
genic mice with disruptions in specific glycosyltransferase
genes, and thus deficient in downstream ganglioside biosyn-
thesis, have been critical tools in advancing understanding of
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their roles. Mice generated with a disruption in the B4galnt1
gene are deficient in GalNAcT but are viable and appear
grossly normal, indicating that complex ganglioside expres-
sion is not necessary for normal development (Takamiya et al.,
1996) but later develop an age-dependent neurodegenerative
phenotype characterized by weakness, ataxia, nerve degenera-
tion and demyelination, and loss of nodal axo-glial junction
adhesion and integrity (Sheikh et al., 1999; Chiavegatto et al.,
2000; Susuki et al., 2007). Overexpression of the precursor simple
gangliosides GM3, GD3, and 9-O-Ac(etyl)-GD3 in GalNAcT/
mice may play a compensatory developmental role that limits
the severity of the phenotype (Ngamukote et al., 2007; Furukawa
et al., 2008).
Mice lacking b-series gangliosides (GD3s/) are grossly nor-
mal throughout life but repair peripheral nerve poorly (Kawai et
al., 2001;Okada et al., 2002).Micewhose ganglioside repertoire is
restricted to GM3 (GalNAcT/  GD3s/ double knock-out)
develop lethal audiogenic seizures (Kawai et al., 2001), age-
dependent progressive motor and cognitive deficits (Tajima et
al., 2009), and sensory loss (Inoue et al., 2002). Complete gangli-
oside ablation is not embryonic lethal; however, from 2 weeks of
age, mice undergo progressive and severe neurodegeneration re-
sulting in death at2months (Yamashita et al., 2005). Together,
these mouse data are suggestive of a more fundamental necessity
for a-series gangliosides in age-related nervous system mainte-
nance, although this is difficult to conclusively prove because a
mouse with selective deficiency of a-series gangliosides has not
been generated. Humans with inherited ganglioside deficiency
also develop complex neurodevelopment and degenerative syn-
dromes (Simpson et al., 2004; Boukhris et al., 2013).
Although these studies indicate that bodywide expression of
simple gangliosides are sufficient to promote viability and complex
gangliosides are required for nervous system maintenance,
stability, and repair, it is unknown whether neuronal or glial
ganglioside deficiency has the greater impact on the age-related
phenotype andmaintenanceof the axon,myelin, andaxo-glial junc-
tion. To assess the relative significance and necessity of complex
ganglioside expression in neuronal and myelin-forming cells, we
developedGalNAcT/ rescuemice that selectively express ganglio-
sides either neuronally [GalNAcT driven by the neurofilament-
light (NFL) promoter; GalNAcT/-Tg(neuronal)] or in myelin
[GalNAcT driven by the proteolipid protein (PLP) promoter;
Figure 1. Expression of GalNAcT and complex gangliosides in rescuemice. A, Constructs were generated to drive GalNAcT expression in the neurons and glia of GalNAcT/mice by promoting
the GalNAcT gene under the control of the hNFL andmPLP promoters, respectively. B, Ganglioside biosynthetic pathway. The GalNAcT enzyme is necessary for generation of complex gangliosides
(surroundedby the greenbox). C, TLC of extracts from brains ofWT, GalNAcT/, GalNAcT/-Tg(neuronal), and GalNAcT/-Tg(glial)mice, sprayedwith resorcinol to label gangliosides.
Standards for the complex gangliosides GM1, GD1a, GD1b, and GT1b are labeled in the right lane. WT extracts contain all complex gangliosides, which are absent from GalNAcT/
extract and restored in GalNAcT/-Tg(neuronal) and GalNAcT/-Tg(glial) mice. GalNAcT/ extracts are enriched with simple gangliosides. GalNAcT/-Tg(neuronal) and
GalNAcT/-Tg(glial) mice extracts are also enriched with simple gangliosides and additionally express the complex gangliosides but at lower levels than WT. D, Chromatograms of
extracted major gangliosides in mouse brains of all genotypes confirm TLC findings. All major gangliosides can be putatively detected. The complex gangliosides GT1b, GD1b, GD1a, and
GM1 are the most abundant gangliosides found inWT extracts. These are also present in rescue mice at lower levels. GD3, 9-O-Ac(etyl)-GD3, and GM3 are highly abundant in GalNAcT/
extracts and remain at high levels in both rescue mice.
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GalNAcT/-Tg(glial)] and analyzed them for behavioral and
structural abnormalities.
Materials andMethods
Generation of transgenic mice
The generation of GalNAcT/ mice lacking complex gangliosides has
been described previously (Takamiya et al., 1996) and backcrossed seven
generations on a C57BL/6 background. Transgenic mice expressing the
full-length cDNA encoding GalNAcT under the control of the NFL or
PLP promoter were generated by pronuclear injection to produce neu-
ronal and glial expression, respectively (Fig. 1A). The activity of the NFL
and PLP promoters are classically restricted to mature neurons and my-
elinating glia (oligodendrocytes and Schwann cells), respectively. GalN-
AcT cDNA was cloned into the pGCHNF-L vector (provided by J.-P.
Julien, Laval University, Quebec, Quebec, Canada) for generating NFL–
GalNAcT transgenic mice. Similarly, GalNAcT cDNA was cloned into
PLP–SV40 (provided by Wendy Macklin, University of Colorado,
Boulder, CO) for generating PLP–GalNAcT transgenic mice. Trans-
genic lines and germ-line transmitters were identified by PCR and
backcrossed seven generations on a C57BL/6 background. NFL–Gal-
NAcT and PLP–GalNAcT were then interbred withGalNAcT/mice to
createGalNacT/-Tg(neuronal)andGalNacT/-Tg(glial)mice, respectively,
thatwereused inall analyses.Evidence forGalNAcTenzymeactivity restoration
and complex gangliosides synthesis in neural tissues were confirmed by gly-
cosyltransferase activity assays as described previously (Ruan and Lloyd,
1992;Ruanet al., 1995).Miceof either sexwerekilledbyCO2 inhalation, and
all experiments complied with United KingdomHomeOffice guidelines.
Antibodies and reagents
Anti-ganglioside antibodies (AgAb) were generated as described previ-
ously (Bowes et al., 2002; Boffey et al., 2005); herein we used the mono-
clonal antibodyMOG16 that reacts with complex gangliosidesGD1b and
GT1b, the latter being prominently restored in GalNacT/-
Tg(neuronal) and GalNacT/-Tg(glial) mice (Fig. 1C,D). Immuno-
staining reagents were sourced as follows: -bungarotoxin (BTx;
Invitrogen); rabbit anti-Caspr (diluted 1:1000; gift from Elior Peles, Re-
hovot, Israel); rabbit anti-Kv1.1 (diluted 1:200; Alomone Labs); mouse
anti-Caspr (diluted 1:500; NeuroMab); rabbit anti-Nav1.6 (diluted
1:100; Sigma); rabbit anti-neurofilament (diluted 1:750; Affinity Biore-
agents); isotype-specific (IgG1, IgG2a, IgG2b, IgG3) Alexa Fluor 488-
and 555-conjugated anti-mouse IgG antibodies; and Alexa Fluor
488- and 555-conjugated anti-rabbit secondary antibodies. Ringer’s so-
lution (in mM: 116 NaCl, 4.5 KCl, 1 MgCl2, 2 CaCl2, 1 NaH2PO4, 23
NaHCO3, and 11 glucose, pH 7.4) was pregassed with 95% O2/5% CO2.
Lipid analysis
Extraction and TLC. Gangliosides were extracted from brains removed
and snap frozen from WT, GalNAcT/, GalNAcT/-Tg(neuronal),
and GalNAcT/-Tg(glial) (2–4 months old) mice according to Wil-
liams and McCluer (1980). Briefly, lipids were extracted from homoge-
nized tissue in 1:1 CHCl3/MeOH. Gangliosides were phase partitioned
into the upper phase according to Folch et al. (1951) and then desalted
using SepPak C18 cartridges. TLC was performed on high-performance
TLC silica plates (Merck) in the solvent system 50:42:11 CHCl3/MeOH/
0.2% CaCl2. Bands were detected with resorcinol.
Liquid chromatography tandemmass spectrometry analysis of lipids. Ex-
tracts were separated on an Ultimate 3000 HPLC system running a 50–
100% isopropanol/10 mM ammonium formate gradient at 250 l/min.
WT, GalNAcT/, GalNAcT/-Tg(neuronal), and GalNAcT/-
Tg(glial) rescue extracts were diluted 1:100 in methanol, and 10 l was
injected onto anAcclaimC30 2.1 150mm5mreverse-phase column
(Thermo Fisher Scientific). Data were acquired on an LTQOrbitrap Elite
equippedwith a heated electrospray ionization source at 80°C in negative
ion mode. Full scans were taken from mass-to-charge ratio 500–2000 at
60,000 resolution. Collision-induced dissociation fragmentation was
performed on the top five peaks in each full scan. Commercial extract
and blanks were run at the beginning and end of the batch.
Data analyses. Extracted ion chromatograms were produced for gan-
glioside elution by applying mass filters for the d18:1/18:0 species of the
[M-H]-ions of GM1, GM2, GM3 and [M-2H]2-ions of GD1, GD3, GT1,
GQ1, and 9-O-Ac(etyl)-GD3 to each dataset for WT, GalNAcT/,
GalNAcT/-Tg(neuronal), and GalNAcT/-Tg(glial) extracts in
Xcalibur qual browser. Normalized intensities were taken for each gan-
glioside from extracted ion chromatograms of the d18:1/18:0 and d18:1/
20:0 species. Retention times were used to verify consistency between
samples. Ganglioside identifications were confirmed and isomers distin-
guished using preestablished fragmentation patterns.
Behavioral assessment
Rotarod. Mice [WT, n  27; GalNAcT/, n  23; GalNAcT/-
Tg(neuronal), n 44;GalNAcT/-Tg(glial), n 20] were placed on the
beam in separate lanes of the rotarod apparatus, and the speed was fixed
at 15 rpm. Mice were trained three times a day for 3 consecutive days to
allow familiarization with the equipment. Latency to fall from the rod
was recorded for up to 100 s each trial for three trials per day on 3
consecutive days. The nine results were then pooled for each mouse.
Hindlimb grip strength. A rectangular metal bar was attached to a dig-
ital force gauge (Chatillon DFIS; AMETEK) and set to record the maxi-
mum tensile force generation (in Newtons). Each mouse was suspended
by the tail, and tensile force generated by the forelimb grip on the longest
aspect of the metal bar was measured. Total tensile force generated by
both forelimbs and hindlimbs was then measured. The mouse was then
gently pulled back until its grip on the bar was released. Each mouse was
measured three times a day for 3 d, and the mean force generated by the
hindlimbwas calculated by subtracting force generated by forelimb from
total force (generated by forelimb and hindlimb).
Grid walking. This test assessed accurate paw placement and paw slips
during recorded 10 min free-walking sessions on a wire grid. A paw slip
consisted of a paw completely missing a rung resulting in the limb falling
through the grid or an initially successful paw placement that subse-
quently slipped through the grid attributable to limbweakness on weight
bearing. Each hindlimb forward motion counted as one step, and 500
steps were counted for each mouse.
Ultrastructural analyses
Tissue for electron microscopy was dissected from mice transcardially
perfused with 5% glutaraldehyde/4% paraformaldehyde mixture. The
second segment of the cervical spinal cord, the optic nerve (OpN), and
sciatic nerve (SN) were processed for resin embedding (Griffiths et al.,
1981). Sections were cut for both light and electron microscopy. Tissue
from 2- and 12-month-old mice (n  4 per genotype, n  3 WT) were
studied for ultrastructural analysis. Electron micrographs from trans-
verse sections of the OpN and the ventral columns of the spinal cord at
6700 and 2700magnification, respectively, were taken on a Jeol CX-
100 Electron microscope. Images from 1 m semithin sections stained
with methylene blue/azurII were captured of the SN at 100magnifica-
tion. For quantification, a minimum of 10 electron micrographs or six
digital light microscopic images per animal were taken of randomly se-
lected fields. All measurements were made on scanned or digitally cap-
tured images using NIH ImageJ software.
Axon morphometry and quantification of axonal changes. All axons
within or touching the top and left borders of an area of interest (AOI)
were counted. The axon density, number of degenerating axons, or those
containing accumulations of organelles within the AOI was counted.
The volume occupied by compact myelin or axoplasm was quantified
by a point counting method using an appropriately sized grid (Williams,
1977) and expressed as the ratio of the number of intercepts coinciding
with the structure to the total number of intercepts.
Immunohistochemistry, imaging, and analysis
Ganglioside localization. Triangularis sterni (TS) muscles (n 3 per ge-
notype, 6 months) were maintained in Ringer’s solution and incubated
in 100g/ml AgAb for 30min at 4°Cwith 2g/ml FITC-conjugated BTx
to label the neuromuscular junctions (NMJs). Spinal cord (n  3 per
genotype, 6 months) were snap frozen on removal, transversely cryosec-
tioned at 10monto 3-aminopropyltriethoxysilane (APES)-coated glass
slides, and then incubated with 20 g/ml AgAb and anti-neurofilament
antibody to identify axons (1:750) in PBS for 2 h at 4°C. All preparations
were washed in Ringer’s solution or PBS before 20 min fixation in 4%
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paraformaldehyde at room temperature, followed by 10minwashes with
PBS, 0.1 M glycine, and PBS. Tissues were incubated with appropriate
isotype-specific fluorescently labeled secondary antibodies at 2g/ml for
1 h at room temperature (cord) or 5 g/ml with 1% normal goat serum
overnight at 4°C (TS), washed with PBS, and finally coverslipped, or
mounted and coverslipped in the case of TS. Images were captured on a
Zeiss Axio Imager Z1 with ApoTome attachment.
Nodal integrity assessment. Fixed SN and OpN (n 3 per genotype, 6
months) were teased into individual fibers or sectioned at 10m, respec-
tively, on to APES-coated glass slides. Nerves were incubated with block-
ing solution (3% normal goat serum plus 0.5% Triton X-100 in PBS) for
30 min at 4°C before incubation overnight in the same solution plus
primary antibodies (rabbit anti-Kv1.1 and mouse anti-Caspr). Nerves
were washed in PBS and incubated for 3 h at room temperature with
appropriate combination of fluorescently labeled secondary antibodies
each at 2 g/ml. Several features of nodal architecture were examined
(and quantified in SN), including juxaparanodal (JPN) Kv1.1 channel
immunostaining invasion into paranodes, the distance between Kv1.1-
positive domains, paranodal (PN) Caspr protrusions and the length of
Caspr, and Nav1.6 staining. Nodes of Ranvier (NoR) were identified in
phase contrast and by Kv1.1 channel staining. At least 20 nodes per
mouse were imaged and assessed using NIH ImageJ software.
Extracellular SN recordings
Nerves were mounted in a Perspex recording block across three cham-
bers and sealed in with vacuum grease. SNs were maintained in Ringer’s
solution, and recordings were performed at room temperature. To mea-
sure conduction velocity (CV) and rate of rise, nerves were stimulated at
1 Hz and supramaximal voltage (Grass S88 stimulator; Grass Instru-
ments) for 30 min. Signals were amplified (CED1902; Cambridge Elec-
tronic Design), digitized (NIDAQ-MX analog-to-digital converter;
National Instruments), and analyzed usingWinWCP version 4.5.2. Sub-
sequently, paired-pulse recordings were performed on the same nerve to
assess refractoriness; intervals between stimuli ranged from3 to 30ms. At
termination, 5 M tetrodotoxin was applied or nerve crush was per-
formed to confirm that the recorded waveform originated from the
opening of sodiumchannels. Aminimumof 200 control waveformswere
used to calculate CV and rate of rise. To determine refractoriness, the
percentage amplitude of the second waveform compared with the first
was calculated for every interstimulus interval and plotted. Four- to
6-month-old mice were used [n  3 for WT; n  4 for GalNAcT/-
Tg(neuronal); n 5 for GalNAcT/ and GalNAcT/-Tg(glial)]; both
nerves were used for recordings permouse. A one-way ANOVAwas used
to compare CV and rate of rise among genotypes and two-way ANOVA to
compare paired-pulse amplitudes with increasing interstimulus interval.
Statistics
Statistical analyses were performed using GraphPad Prism 6 (GraphPad
Software), and statistical significance was set at p 0.05. Data in figures
are presented as mean  SEM. Behavioral data among genotypes was
compared by two-way ANOVA, followed by Tukey’s post hoc tests for
multiple comparisons; one-way ANOVA was applied to morphological
studies and electrophysiological recordings, followed by Tukey’s post hoc
analysis.
Results
GalNAcT enzyme activity and complex ganglioside expression
is restored in neural tissue ofGalNAcT/-Tg(neuronal) and
GalNAcT/-Tg(glial)mice
Four neuronal and four glial transgenic lines were backcrossed
onto GalNAcT/ and screened for GalNAcT enzyme activity in
whole-brainhomogenate and for complex ganglioside expression in
neural tissue by immunohistology. One line of each was then se-
lected for additional study based on the highest enzyme activity. In
the two selected lines, whole-brain GalNAcT enzyme activity (com-
pared with WT, 100%) was present at 5.3% in GalNAcT/-
Tg(neuronal) and 11.7% inGalNAcT/-Tg(glial) andundetectable
in whole-brain homogenate fromGalNAcT/mice.
To characterize complex ganglioside profiles, ganglioside
fractions were extracted from brains for resorcinol staining of
TLC and accurate molecular mass identification using liquid
chromatography mass spectrometry (Fig. 1C,D). TLC of brain
extracts confirmed the presence of complex gangliosides in ex-
pected profiles (Fig. 1C).WTbrain contains a full complement of
simple and complex gangliosides, with greater expression of the
complex gangliosides GD1a, GT1b, GM1, and GD1b, as also in-
dicated by liquid chromatography mass spectrometry (Fig. 1D).
In GalNAcT/ brain, complex gangliosides are absent; instead,
GM3, GD3, and 9-O-Ac(etyl)-GD3 that are upstream of GalN-
AcT in the biosynthetic pathway are highly enriched, as reported
previously (Takamiya et al., 1996; Furukawa et al., 2008). Enrich-
ment of these simple gangliosides is maintained inGalNAcT/-
Tg(neuronal) and GalNAcT/-Tg(glial) brain; additionally, the
complex gangliosides GD1a, GT1b, GM1, and GD1b are also
present at approximately equal levels in each strain and at lower
levels than inWTbrain. Based on the normalized intensities from
the extracted ion chromatogram of the D18:1/18:0 species for
each complex ganglioside, restoration levels are 25–40% of WT
whole-brain values. The lower levels of complex gangliosides
seen in both GalNAcT/-Tg(neuronal) and GalNAcT/-
Tg(glial) shown by TLC and enzyme activity assays compared
with WT may be in part attributable to a dilution effect, because
analyses were conducted onwhole brain. The enrichment of sim-
ple gangliosides in the rescue strains is likely attributable to re-
stricted cell specificity of the transgenic GalNAcT enzyme, with
consequent buildup in the un-rescued tissue compared with the
global expression of GalNAcT in WT brain.
Immunostaining of PNS and CNS tissue was performed using
AgAbs to delineate cell specificity of the transgenically reinstated
gangliosides (Fig. 2). Monoclonal antibodies raised against com-
plex gangliosides were applied to spinal cord sections and ex vivo
whole-mount TS nerve–muscle preparations to demonstrate ap-
propriate expression in CNS and PNS among genotypes and
compare fluorescence levels as an indication of expression levels
in the target membranes. Despite lower levels of whole-brain
ganglioside as determined by TLC above, AgAb immunostaining
at similar levels was evident in the distal axon of theNMJ and also
on spinal cord ventral column fibers in WT and GalNAcT/-
Tg(neuronal)mice (Fig. 2). Complex ganglioside expression was
absent on axons ofGalNAcT/mice as expected. InGalNAcT/-
Tg(glial) mice, pronounced immunostaining was observed at
sites corresponding to perisynaptic Schwann cells overlying the
nerve terminal (in which the PLP promoter is active;Michalski et
al., 2011) and surrounding neurofilament immunoreactivity in
ventral spinal cord. It is not possible to establish whether the latter
immunostaining ispresenton theaxonalmembraneor theadaxonal
myelin membrane at this level of resolution, because the twomem-
branes are very closely apposed.With somemonoclonal antibodies,
we observed perisynaptic Schwann cell labeling at the NMJ of
GalNAcT/-Tg(neuronal)mice, consistentwith activity of theNFL
promoter in non-myelinating Schwann cells (Haynes et al., 1999;
data not shown). However, primary cultures of Schwann cells and
oligodendrocytes fromGalNAcT/-Tg(neuronal)mice were nega-
tive when immunostained with AgAbs to complex gangliosides
compared with positiveWT glial cultures (data not shown).
Neuronal but not glial expression of GalNAcT attenuates the
behavioral deficits seen inGalNAcT/mice
Because GalNAcT/ mice exhibit age-dependent locomotor
deficits, we performed behavioral tests to assess the impact of
neuronal and glial complex ganglioside rescue on motor coordina-
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tion, strength, gait, and balance. Mice of all genotypes maintained a
normal lifespan; however,GalNAcT/ andGalNAcT/-Tg(glial)
mice developed a severe locomotor deficit with age, manifested
most obviously by hindpaw clasping and impaired extension
(Fig. 3A) and a markedly ataxic gait with pronounced tremor.
Interestingly, old (18 months) GalNAcT/-Tg(glial) mice
exhibited excessive facial scratching with excoriation and hair
loss, not seen in other genotypes, includingGalNAcT/ (data
not shown). GalNAcT/-Tg(neuronal) mice appeared nor-
mal throughout life, indistinguishable from WT.
On quantitative testing, hindlimb grip strength is similar in
the four genotypes at 2–3months and then significantly and pro-
gressively deteriorates (two-way ANOVA, p 0.001; Fig. 3B) in
GalNAcT/ and GalNAcT/-Tg(glial)mice from 6 months of
age, as revealed by post hoc tests. GalNAcT/ and GalNAcT/-
Tg(glial)mice also exhibit equally poor motor performance and
coordination that progresses with age as determined by a reduced
latency to fall from the rotarod (two-wayANOVA, p 0.001; Fig.
3C) and an increase in the number of foot falls on grid walking
(two-way ANOVA, p  0.001; Fig. 3D). There is no significant
difference in task performance between WT GalNAcT/-
Tg(neuronal)mice.
Morphological appearances as a function of complex
ganglioside expression in neurons and glia
Ultrastructural abnormalities in GalNAcT/ mice principally
include an age-dependent increase in degenerate axon number,
abnormal myelination (CNS dysmyelination and PNS demyeli-
nation), loss of innermost PN transverse bands, and axolemmal
protrusions at the NoR (Sheikh et al., 1999; Sugiura et al., 2005;
Susuki et al., 2007). Therefore, we assessed these parameters in
groups of normal,GalNAcT/,GalNAcT/-Tg(neuronal), and
GalNAcT/-Tg(glial) mice at young (2 months) and aged (12
months) time points to determine whether neuronal or glial gan-
glioside expression was critical to the development of these path-
ological abnormalities and that correlated with behavioral
Figure 2. Restoration of complex ganglioside expression in PNS and CNS tissue identified by anti-ganglioside mAb immunostaining. Complex ganglioside at the NMJ (PNS) and in the ventral
spinal cord (CNS) are labeled bymousemonoclonal AgAb, followed by detectionwith a fluorescently labeled anti-mouse IgG antibody (green inmerged images). In nerve–muscle preparations, the
NMJs are identified by fluorescently conjugated BTx, which binds the AChR on the postsynapticmembrane. The axons of ventral columns in spinal cord sections are identified by anti-neurofilament
antibody (red). Complex gangliosides are present on nerve fiber axolemma in WT and GalNAcT/-Tg(neuronal) mice in both preparations and absent in the GalNAcT/ mice. Perisynaptic
Schwann cells at themotor nerve terminal of the GalNAcT/-Tg(glial)mice are positive for AgAb, and AgAb immunoreactivity also surrounds the neurofilamentmarker in the ventral spinal cord.
Scale bars, 10m.
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performance. None of the parameters measured were signifi-
cantly different among the four genotypes at 2 months (data not
shown); however, by 12 months, significant pathological devia-
tions in genotypes were seen (Fig. 4), confirming the age-
dependent nature of neurodegeneration and corresponding to
the timeframe of the development of behavioral deficiencies.
At 12 months of age, the density (cord) or number (OpN and
SN) of degenerate axons is significantly greater in both GalN-
AcT/ and GalNAcT/-Tg(glial) SN and in OpN for GalN-
AcT/ and ventral spinal cord for GalNAcT/-Tg(glial)
compared with WT and GalNAcT/-Tg(neuronal) mice (one-
way ANOVA, p  0.05; Fig. 4A). In contrast GalNAcT/-
Tg(neuronal)mice have no significant axon degeneration in any
of the three sites assessed compared with WT. Degenerate axons
are indicated by red arrowheads in representative images in Fig-
ure 4C. Average myelin volume varies significantly among geno-
types (one-way ANOVA, p  0.05) and also varies between
neural tissues (Fig. 4B). GalNAcT/ and GalNAcT/-Tg(glial)
myelin volume is significantly reduced compared with WT mice
in all three sites.GalNAcT/-Tg(neuronal)myelin volumes does
not significantly differ fromWT in any site. Together, these find-
ings indicate thatGalNAcT/-Tg(glial)mousemorphology (de-
generate axon number and myelin volume) is not significantly
different fromGalNAcT/, whereas neuronal expression of gan-
gliosides inGalNAcT/-Tg(neuronal) is sufficient to attenuate age-
related axonal degeneration andmyelin volume changes.
In qualitative observations, abnormal organelle-filled axons
and redundant myelin (Fig. 4C, indicated by red asterisks and
arrows, respectively) were frequently observed in OpN axons
from GalNAcT/ and GalNAcT/-Tg(glial) mice. Whereas
myelin volume measurements were quantitatively normal in
GalNAcT/-Tg(neuronal) mice, the myelin appeared looser
than in WT, suggesting that subtle defects in compaction were
not ameliorated in either this or theGalNAcT/-Tg(glial)mice.
Restoration of nodal architecture by neuronal expression of
complex gangliosides
The aberrant distribution of nodal ion channels (Kv1.1 and
Nav1.6) described previously inGalNAcT/mice (Susuki et al.,
2007) indicates a role for complex gangliosides in the mainte-
nance of nodal domains. In both SN (PNS) and OpN (CNS),
rectification of nodal ion channel localization to discrete do-
mains was observed after neuronal, but not glial, expression of
complex gangliosides (Fig. 5). In the SN of GalNAcT/ and
GalNAcT/-Tg(glial) mice, immunohistology reveals signifi-
cant invasion of the PN with JPN potassium channels (Kv1.1)
compared withWTmice (Fig. 5A,B, indicated by orange arrows;
one-way ANOVA, p  0.05). In GalNAcT/-Tg(neuronal)
mice, Kv1.1 localization is restored to normal. A consequence of
the Kv1.1 PN invasion in GalNAcT/ and GalNAcT/-
Tg(glial)mice is a reduction in the distance between JPN Kv1.1-
positive domains compared with WT, whereas Caspr staining
lengths remain similar (Fig. 5A–C; one-way ANOVA, p 0.001),
thereby effectively indicating an overlap in Kv1.1 and Caspr
staining at the PN/JPN border. In contrast, in GalNAcT/-
Tg(neuronal) mice, the inter-Kv1.1 distance and Caspr staining
domains are significantly longer than in GalNAcT/ and
GalNAcT/-Tg(glial) mice (Figure 5A–C; one-way ANOVA,
p  0.01). The number of PN protrusions filled with Caspr im-
munoreactivity were significantly greater in GalNAcT/ and
GalNAcT/-Tg(glial) mice compared with both WT and
GalNAcT/-Tg(neuronal) mice (Fig. 5A–C; one-way ANOVA,
p  0.05, indicated by white arrows). These protrusions do not
contain neurofilament immunoreactivity, suggesting that they
Figure 3. Neuronal but not glial expression of complex gangliosides in GalNAcT/mice rescues behavioral deficiencies. A, Hindpaw extension on lifting by the tail occurs in WT mice; this is
replicated in GalNAcT/-Tg(neuronal)mice, but abnormal clasping of the hindpaws occurs in GalNAcT/ and GalNAcT/-Tg(glial)mice. Grip strength (B), latency to fall from the rotarod (C),
and number of foot slips (D) are comparable among genotypes at 2months. There is significant deterioration with age in GalNAcT/ and GalNAcT/-Tg(glial)mice (2-way ANOVA, p 0.001)
compared with WT and GalNAcT/-Tg(neuronal). *** indicates significance compared with WT; ### signifies significance compared with neuronal rescue. *p 0.05; *** and ###, p 0.001.
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are attributable to discrete local distur-
bances in themembrane rather than alter-
ations in neurofilament ultrastructure
(data not shown). The lateral extent of
Nav1.6 immunostaining increased with
loss of complex gangliosides comparedwith
WT and remained increased in both
GalNAcT/-Tg(glial) and GalNAcT/-
Tg(neuronal) mice (Fig. 5B,C). These re-
sults suggest a role for complementary
complex ganglioside expression in closely
apposed membranes and the reliance on
these lipid interactions for the fine-tuning
of domain organization.
Ultrastructural examination of longi-
tudinal sections through WT SN NoR
demonstrates individual PN loops align-
ing with the axon, connected by trans-
verse bands (Fig. 5D). In all three complex
ganglioside-deficient genotypes, the PN
loops appear disorganized and aberrantly
stacked, particularly at the nodal/PN
region in GalNAcT/-Tg(glial) and
GalNAcT/-Tg(neuronal) mice. These
focal areas of disorganization may corre-
spond to the sites of Caspr-filled protru-
sions observed by immunostaining.
Whereas transverse bands between axons
and PN loops are absent at the PN/JPN
border ofGalNAcT/mice, we observed
that they were present here both in
GalNAcT/-Tg(glial) and GalNAcT/-
Tg(neuronal) mice (Fig. 6, enlargements
shown in insets). The neurofilament
appears normal in all genotypes in this
region.
Electrophysiological examination of SN
In view of the ion channel and nodal ar-
chitecture abnormalities, degenerate ax-
ons, and myelin volume loss present in
ganglioside null and rescue mice, we per-
formed ex vivo extracellular recordings on
SN from the different genotypes. Subtle
reductions in CV were seen in all
ganglioside-deficient mice compared
with WT, but this did not reach signifi-
cance (Fig. 7A). There is a significant dif-
ference in rate of rise of the compound
nerve action potential in all genotypes
compared withWTmice (Fig. 7B,C; one-
way ANOVA, p  0.01). Paired pulse re-
cordings show that refractoriness is not
altered in GalNAcT/, GalNAcT/-
Tg(glial), or GalNAcT/-Tg(neuronal)
mice compared withWT (Fig. 7D). These
results suggest that the behavioral pheno-
type is not accounted for by SN conduc-
tion slowing because recovery of the
behavioral phenotype in neuronal rescue
mice is not mirrored by an improvement
in conduction. It is likely that changes to
the refractory period were not detected
Figure 4. Prevention of morphological abnormalities in neuronal but not glial rescue mice. A, Degenerate axon density or
number is greater in 12-month-old GalNAcT/mice and reaches significance in OpN and SN compared with age-matched WT
mice. Neuronal expression of complex gangliosides significantly attenuates this degeneration, whereas degenerate axon density
and number in glial rescuemice remains significantly greater in spinal cord and SN, respectively. B, Myelin volume is significantly
reduced in all tissues studied for GalNAcT/ and GalNAcT/-Tg(glial) mice compared with WT and also compared with
GalNAcT/-Tg(neuronal) in SN. C, Representative EM and lightmicroscopic images from transverse sections of spinal cord, OpN,
and SN for all genotypes show normalization of axon and myelin in neuronal rescue mice and increased degenerate axons
(indicated by red arrowheads), myelin thinning, and poorer ultrastructure in GalNAcT/ and GalNAcT/-Tg(glial) mice.
Organelle-filled axons and redundant myelin occurred frequently in GalNAcT/ and GalNAcT/-Tg(glial) mice OpN and are
indicated by red asterisks and arrows, respectively. One-way ANOVA, *p 0.05, **p 0.01, ***p 0.001. Scale bars: Cord, 2
m; OpN, 1m; SN, 25m.
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Figure 5. Restoration of normal nodal architecture by expression of complex gangliosides in neurons of GalNAcT/mice. A, Representative illustrative images per genotype of Caspr (green) and Kv1.1
(magenta) immunoreactivity at SNandOpNNoR in6-month-oldmice. InSNKv1.1, invasion into thePN is indicatedbyorangearrows (SNandOpN)andCasprprotrusions (SNonly)bywhitearrows.B, Invasion
of thePN(identifiedbyCaspr)withJPNmarkerKv1.1stainingsignificantly increased inGalNAcT/andGalNAcT/-Tg(glial)micecomparedwithWTandGalNAcT/-Tg(neuronal)miceSN.Consequently,
thedistancebetweenKv1.1-positivedomains significantlydecreased forbothgenotypes. Thisdistancewas lengthened inGalNAcT/-Tg(neuronal)micecomparedwithWT.ThenumberofPNCaspr staining
protrusions significantly increased forGalNAcT/ andGalNAcT/-Tg(glial) SN comparedwithWTandGalNAcT/-Tg(neuronal) levels,whichwere comparable. ComparedwithWTnerve, Caspr staining
was significantly lengthened in GalNAcT/-Tg(neuronal) nerve. Conversely, Caspr staining length was significantly shorter in GalNAcT/ and GalNAcT/-Tg(glial) SN compared with GalNAcT/-
Tg(neuronal). The length of Nav1.6 immunostaining significantly increased inGalNAcT/ andboth rescuemice comparedwithWT. C, To scale, schematic representing the length of staining in each domain
pergenotype.One-wayANOVA,p0.05.*signifiessignificancecomparedwithWT;#signifiessignificancecomparedwithGalNAcT/-Tg(neuronal).*and #,p0.05;**and ##,p0.01;***and ###,p
0.001. Scale bar, 10m.
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because of very subtle invasion of the
paranodes by Kv1.1 channels.
Discussion
Many neurological abnormalities associ-
ated with global complex ganglioside de-
ficiency achieved through targeted gene
knock-out have been described previously
(Takamiya et al., 1996; Sheikh et al., 1999;
Chiavegatto et al., 2000; Sugiura et al.,
2005; Susuki et al., 2007). However, the
precise cellular contribution to these
phenotypes has never been investigated.
Herein, through selective reintroduction
of glycosyltransferase activity in a site-
specific manner, we find that neuronal,
and not glial, rescue of complex ganglio-
sides is both necessary and sufficient to
prevent the age-dependent neurodegen-
erative phenotype seen in global GalN-
AcT/ deficiency states. These findings
clearly demonstrate the importance of
neuronally expressed GalNAcT in main-
taining nervous system integrity through-
out the lifespan.
Certain technical caveats may affect
the interpretation of these results. The tar-
geting strategy we adopted used NFL and
PLP promoters to drive GalNAcT expression in a cell-restricted
manner to neurons and myelin-forming glia, respectively. Al-
though both vectors have been used widely to achieve this, it is
recognized that, at different stages of mouse development and in
different neuronal and glial subtypes, these promoter activities
may bemore promiscuously active than generally stated (Haynes
et al., 1999;Michalski et al., 2011). For example, transient expres-
sion of neurofilament mRNA has been described in non-
myelinating Schwann cells (Fabrizi et al., 1997; Sotelo-Silveira et al.,
2000), thereby providing one explanation for the presence of
complex ganglioside immunoreactive perisynaptic Schwann cells
we observed at the GalNAcT/-Tg(neuronal) mouse NMJ.
However, the absence of complex gangliosides in cultured
Schwann cells and oligodendrocytes provides overall confidence
in the validity of using theNFL promoter for thismodel. Further-
more, the activity of the natural GalNAcT promoter and of the
enzyme itself, which is highly regulated in developmental and
spatial patterns, is not recapitulated in these transgenic mice,
especially when considering that the regional patterns of brain
ganglioside composition will change continuously throughout
life (Segler-Stahl et al., 1983; Ikarashi et al., 2011). It is also known
that gangliosides can transfer between membranes by shedding
and uptake (Olshefski and Ladisch, 1996; Lauc and Heffer-Lauc,
2006). Indeed, substantial levels of different gangliosides circu-
late in the plasma and may be derived from dietary intake or
acquired transplacentally from heterozygous dams used in our
breeding programs (McJarrow et al., 2009; Mitchell et al., 2012).
Therefore, it is possible that glial membranes might acquire com-
plex gangliosides from neuronal membranes in GalNAcT/-
Tg(neuronal)mice and vice versa, regardless of their primary site of
biosynthesis.
Notwithstanding these caveats, our analyses demonstrate that
site-specific reintroduction of complex gangliosides has been
achieved.GalNAcT/micehave increased expressionof the simple
gangliosides (Takamiya et al., 1996; Furukawa et al., 2008). Both
GalNAcT/-Tg(neuronal) and GalNAcT/-Tg(glial) retained
high levels of these simple gangliosides, although we do not know
whether these were present in GalNAcT-deficient cells or were still
accumulated in GalNAcT-replete cells containing rate-limiting lev-
els of enzymeactivity.Although it has beenproposedpreviously that
neurodegeneration in GalNAcT/mice might in part be attribut-
able to a toxic gain of function, our data showing retention of very
high levels of these simple gangliosides would argue that deficiency
of complex gangliosides appear to be the major factor.
Complex gangliosides are present in both axons and glia
(Ogawa-Goto et al., 1992; Svennerholm, 1994; Ogawa-Goto
and Abe, 1998), with greater enrichment of GM1 and GD1a in
axons (Ogawa-Goto and Abe, 1998) and immunostaining
(Gong et al., 2002). Our immunostaining for complex gan-
gliosides was most apparent on the axons rather than myelin in
WT and GalNAcT/-Tg(neuronal)mice and was absent in both
compartments in GalNAcT/ mice. GalNAcT/-Tg(glial)
perisynaptic Schwann cells atmotor nerve terminals were labeled
by AgAbs, and ventral column fibers were also immunopositive. If
indeed complex gangliosides aremore prevalent in the axonal com-
partment in WT mice, this could explain why a rescue of neuronal
complex gangliosides restores the GalNAcT/ phenotype to near
normality, whereas recovery of gangliosides in the glial compart-
ment has no effect.
Behavioral features associated with motor coordination and
balance that are impaired in GalNAcT/ mice (Chiavegatto et
al., 2000) are normalized in GalNAcT/-Tg(neuronal) mice.
Additionally, the characteristic tremor and ataxia observed in the
GalNAcT-deficient mice that has been likened to parkinsonism
(Wu et al., 2011) is also completely attenuated in GalNAcT/-
Tg(neuronal)mice. The precise source(s) of the gross behavioral
abnormalities in GalNAcT/ mice has never been established
because of the remarkably preserved gross brain architecture
(Takamiya et al., 1996) combined with the multitude of cell bio-
logical functions modulated by gangliosides (Wu et al., 2005;
Figure 6. Transverse bands are maintained by expression of complex gangliosides in neurons and glia of GalNAcT/mice.
Representative longitudinal SN EM images demonstrate normal NoR ultrastructural features in WT mice, including ordered ar-
rangement of PN loops and appropriate formation of transverse bands between the axon and glialmembranes (visible in enlarged
inset). Transverse bands are often absent in GalNAcT/ mice but can be identified in both GalNAcT/-Tg(neuronal) and
GalNAcT/-Tg(glial) mice. In GalNAcT/ and both rescue mice, PN loops aberrantly stack and do not all make appropriate
contact with the axolemma. Scale bars, 0.5m.
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Ohmi et al., 2009). A prominent suggestion is that complex gan-
glioside deficiency leads to impairment of axon–myelin stability
and consequent axonal degeneration (Sugiura et al., 2005; Sch-
naar, 2010). The myelin structural abnormalities seen in GalN-
AcT/ mice and their reversal in at least some sites in
GalNAcT/-Tg(neuronal)mice point toward an impairment in
myelination and axo-glial junction formation as at least partially
responsible for the behavioral phenotype rather than being di-
rectly attributable to the rather low frequency of degenerate ax-
ons. Electrophysiologically, we only examined peripheral
myelinated axons; although confirming peripheral CV slowing in
GalNAcT/mice (Susuki et al., 2007), this was not recovered by
neuronal or glial complex ganglioside rescue, indicating that pe-
ripheral nerve CV defects cannot be responsible for the clinical
phenotype, although the situationmay differ in theCNS,which is
the more likely source of the phenotype.
Sodium channel dispersion andmyelin sheath disruption lead
to conduction slowing (Gutie´rrez et al., 1995; Ichimura et al.,
2005). The necessary spatial separation of sodium and potassium
channels at the NoR is provided by PN loop contact with the
axolemma and axo-glial transverse band formation (Rasband et
al., 2003; Rosenbluth et al., 2003). Our immunohistological data
demonstrate lengthened Nav1.6 clusters in the PNS for all
ganglioside-deficient genotypes comparedwithWT,most appar-
ent in GalNAcT/-Tg(glial) mice. This correlates with our CV
data. Additionally, PN loops only form orderly attachments on
the axon in WT mice and instead have stacked PN loops in all
mutants, primarily seen at the nodal border. This suggests that
the abnormal Nav1.6 distribution may be attributable to abnor-
mal PN loop formation. Lengthening of sodium channel do-
mains reported here and previously inGalNAcT/mice (Susuki
et al., 2007) and prominently in GalNAcT/-Tg(glial) mice in-
dicates a breakdown in the nodal/PN border that may be influ-
enced by complex ganglioside interactions with ligands in both
the glial and axonal membranes. Indeed, a breakdown in the
axo-glial junction and subsequent lengthening of sodium chan-
nel domains and PN invasion by Kv channels is also seen in the
sulfatide-deficient mouse (Ishibashi et al., 2002). Unexpectedly,
despite the dogma that potassium channels mislocalize to the
paranodes attributable to loss of transverse bands, here Kv1.1
invasion occurred in GalNAcT/-Tg(glial) mice although we
observed intact transverse bands ultrastructurally, albeit in qual-
itative rather than quantitative observations. It is possible that the
physical barrier provided by transverse bands is only one compo-
nent required for Kv1.1 localization, additionally requiring spe-
cialized lipid raft associated anchoring domains that involve
gangliosides (Gu and Gu, 2011). Normal refractory periods were
recorded in all mice, suggesting that the Kv1.1 channel mislocal-
ization in ganglioside deficiency states is insufficient to directly
result in major functional disruption.
Our principal finding that function is restored by neuronal
rather than glial GalNAcT expression indicates the requirement
for an axonally expressed ligand in fine tuning the interacting
molecules at axo-glial junctions that are required formaintaining
myelin, axonal, and nodal integrity. The complex gangliosides
GD1a and GT1b have been described as axonal ligands for
myelin-associated glycoprotein (MAG) localized on the inner-
most wrap of the myelin sheath (Collins et al., 1997). The age-
related degenerative phenotype, functional, and morphological
deficits displayed by GalNAcT/ mice parallel those found in
Figure 7. Peripheral nerve functional recovery in rescue mice. Analysis of extracellular recordings from 4- to 6-month-old GalNAcT/, GalNAcT/-Tg(neuronal), and Tg(glial) SN show a
reduction in CV that does not reach significance (A).B, Rate of rise of the compound nerve action potential is significantly reduced comparedwithWT for all other genotypes (one-way ANOVA, p
0.05). C, Representative trace for each genotype from which analysis was performed. D, The amplitude of the second pulse per interstimulus interval in paired pulse recordings were plotted per
genotype; therewere no significant changes to refractory period (two-way ANOVA, p 0.05). ** and *** signifies significance comparedwithWT. **p 0.01, ***p 0.001. Individualmice data
are plotted to demonstrate the variance in the recordings among animals.
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MAG null mice and mice created from interbreeding the two
genotypes (Pan et al., 2005). Restoration of MAG–ganglioside
interaction in GalNAcT/-Tg(neuronal) mice might thus ac-
count for at least some components of the preserved phenotype.
Other abundant gangliosides, GM1 and GD1b, are likely to
also have MAG-independent neuroprotective roles. Complex
gangliosides, particularly GM1, are an integral member of
membrane-specific microdomains, lipid rafts (Simons and
Ikonen, 1997), that subservemany signaling and trafficking func-
tions that could be disrupted by ganglioside loss, such as comple-
ment regulator dysfunction (Ohmi et al., 2009). Lipid rafts are
also involved in the recruitment and stabilization of the glial
adhesion molecule neurofascin 155 at the NoR (Schafer et al.,
2004). Indeed, GalNAcT/mice have mislocalized neurofascin
at the NoR (Susuki et al., 2007), andmice lacking neurofascin fail
to develop normal NoR (Sherman et al., 2005), demonstrating
the importance of such an interaction.
The global loss of complex gangliosides results in an obvious
behavioral phenotypewhose specific origin is unknownbut likely
attributable to multiple impairments. Here we show that the
wide-ranging degenerative features and consequent behavioral
phenotype can be overcome by the expression of complex gan-
gliosides limited to neuronalmembranes. Strikingly, glial expres-
sion of complex gangliosides does not have the same effect. This
demonstrates the necessity for site-specific expression of complex
gangliosides in maintenance of the nervous system and opens up
experimental avenues for more precisely defining the role of
complex gangliosides in nervous system maintenance. The dis-
covery of human disorders of ganglioside biosynthesis (Simpson
et al., 2004; Boukhris et al., 2013) and autoimmune disorders in
which gangliosides are targets (Willison and Plomp, 2008) adds
important clinical dimensions to this area.
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